» Articles » PMID: 28208876

Prescribing Pattern of Antifungal Medications at a Tertiary Care Hospital in Oman

Overview
Specialty General Medicine
Date 2017 Feb 18
PMID 28208876
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Inappropriate use of antifungal agents is implicated in the global burden of antifungal resistance, adverse outcomes like persistent infections, unnecessary exposure and increased cost. Data collection from time to time is to be done in order to have a check on the resistance/sensitivity pattern of the commonly prescribed antifungal drugs.

Aim: To describe the pattern of antifungal drug prescription and administration to patients attending a university hospital in Oman.

Materials And Methods: This was a descriptive, retrospective cross-sectional study conducted at Sultan Qaboos University Hospital (SQUH), a university hospital in Oman that covered the electronic patient's data for a period of one year (January 2013 to December 2013). The study included inpatients and outpatients of all ages and both genders attending SQUH and receiving antifungal medications at the study period. Frequencies and percentages were reported for categorical variables, while the mean and standard deviation were used to summarize the data for continuous variables.

Results: A total of 1353 antifungal drug prescriptions were prescribed for 244 patients. More than half of all antifungal drug prescriptions were prescribed by haematology, infectious disease and family medicine departments. The majority of patients to whom these drugs were prescribed were diagnosed to have infectious diseases followed by prophylactic use in leukaemias and immunocompromised conditions. Fluconazole was the most commonly prescribed antifungal drug (n=715, 52.8%) followed by nystatin and voriconazole (n=233; 17.2% and n=152; 11.2%, respectively).

Conclusion: This study will help in understanding antifungal prescription practices and help in directing future studies and also in developing local policies for appropriate use of antifungal drugs.

Citing Articles

Appropriateness of antifungal prescribing in Oman.

El-Hussain F, Balkhair A, Al-Zakwani I, Al Zaabi M Pharm Pract (Granada). 2022; 20(1):2613.

PMID: 35497908 PMC: 9014895. DOI: 10.18549/PharmPract.2022.1.2613.


Detection of antifungal drug-resistant and gene mutations among clinical isolates of species isolated from Khartoum, Sudan.

Mohamed A, Mohamed M, Abdelrahman Hussain M, Fatahalrahman Ahmed I F1000Res. 2021; 9:1050.

PMID: 34035903 PMC: 8114185. DOI: 10.12688/f1000research.24854.2.


Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium.

Johnson M, Lewis R, Dodds Ashley E, Ostrosky-Zeichner L, Zaoutis T, Thompson G J Infect Dis. 2020; 222(Suppl 3):S175-S198.

PMID: 32756879 PMC: 7403757. DOI: 10.1093/infdis/jiaa394.

References
1.
Doan T, Kirkpatrick C, Walker P, Slavin M, Ananda-Rajah M, Morrissey C . Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit. J Antimicrob Chemother. 2015; 71(2):497-505. DOI: 10.1093/jac/dkv343. View

2.
Onnis V, De Logu A, Cocco M, Fadda R, Meleddu R, Congiu C . 2-Acylhydrazino-5-arylpyrrole derivatives: synthesis and antifungal activity evaluation. Eur J Med Chem. 2008; 44(3):1288-95. DOI: 10.1016/j.ejmech.2008.08.003. View

3.
Wali U, Balkhair A, Al-Mujaini A . Cerebro-rhino orbital mucormycosis: an update. J Infect Public Health. 2012; 5(2):116-26. DOI: 10.1016/j.jiph.2012.01.003. View

4.
Menzin J, Meyers J, Friedman M, Perfect J, Langston A, Danna R . Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients. Am J Health Syst Pharm. 2009; 66(19):1711-7. DOI: 10.2146/ajhp080325. View

5.
Caffrey A, Obar J . Alarmin(g) the innate immune system to invasive fungal infections. Curr Opin Microbiol. 2016; 32:135-143. PMC: 4983492. DOI: 10.1016/j.mib.2016.06.002. View